Atlas Trials

A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive Disorder

Clinical trial NCT00191061 · COMPLETED

Trial details

NCT number
NCT00191061
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Depressive Disorder
Start date
2004-10-01
Enrollment
640

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.